Abstract:One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action. One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action.

Case-control study on IL-1RAcP rs16865597 gene polymorphism and susceptibility to essential hypertension in a Chinese Han population

Association Between Polymorphisms of Inflammatory Factor Genes and Coronary Heart Disease

Soluble Guanylate Cyclase Contribute Genetic Susceptibility To Essential Hypertension In The Han Chinese Population

Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals

KLHL3 Single-Nucleotide Polymorphism is Associated with Essential Hypertension in Chinese Han Population.

C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident essential hypertension: findings from an observational cohort of Han Chinese

Hyperplasia Suppressor Gene Polymorphisms and Essential Hypertension: a Case-Control Association Study in a Central Han Chinese Population.

The obesity-related polymorphism PCSK1 rs6235 is associated with essential hypertension in the Han Chinese population

Association between the interleukin-1β C(−511)T polymorphism and blood pressure in a Chinese hypertensive population

Haplotype-based association of regulator of G-protein signaling 5 gene polymorphisms with essential hypertension and metabolic parameters in Chinese.

Interleukin-6 Promoter −174G/C Polymorphism and Hypertension: A Case–control Study and a Meta-Analysis

Associations Between Single Nucleotide Polymorphisms in Mir-221, Self-Reported Essential Hypertension, and Interactions Between Genetic and Environmental Factors: a Multiethnic Study in China.

Haplotype-based Case-Control Study of the Human AGTR1 Gene and Essential Hypertension in Han Chinese Subjects

Associations between polymorphisms of the CXCL12 and CNNM2 gene and hypertension risk: A case-control study

Association of the gene polymorphisms of BMPR2, ACVRL1, SMAD9 and their interactions with the risk of essential hypertension in the Chinese Han population.

Single Nucleotide Polymorphisms in Promoter of Angiotensin II Type 1 Receptor Gene Associated with Essential Hypertension and Coronary Heart Disease in Chinese Population.

Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case–control study and a meta-analysis

Association of Leptin Receptor Gene Polymorphisms and Essential Hypertension in a Chinese Population

The Contributory Role of Angiotensin Receptor-Like 1 Gene Multiple Polymorphisms in Hypertension among Northeastern Han Chinese

Association between RGS5 and ATP1B1 and essential hypertension

Interleukin-16 Gene Polymorphism Is Associated With Acute Coronary Syndrome In The Chinese Han Population